Placebo matching HPP737

DRUG2 trials

Sponsors

Newsoara Biopharma Co., Ltd.

Conditions

Psoriasis

Phase 3

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

CompletedNCT07712705

Newsoara Biopharma Co., Ltd.Psoriasis

Start: 2023-04-20End: 2025-02-20Updated: 2026-08-03

HPP737 in Adult Patients With Plaque Psoriasis

CompletedNCT07712731

Newsoara Biopharma Co., Ltd.Psoriasis

Start: 2025-04-18End: 2026-04-01Updated: 2026-08-03